Nour Al-Mozain: Why Stem Cell Collection Parameters Need Adjustment in SCD for Gene Therapy?
Nour Al-Mozain, Hemopathologist, Consultant at King Faisal Specialist Hospital and Research Center, shared a post on LinkedIn about a recent article by Yvette C Tanhehco et al., published in Blood Advances, adding:
“Stay Steady. Establish the Interface
Why do we need to adjust the standard parameters when collecting stem cells from SCD patients for gene therapy?
- Activated platelets and leukocytes promote aggregation and interface disruption
- Increased blood viscosity causes impaired component separation
- Abnormal RBC morphology leads to altered sedimentation dynamics
SCD blood exhibits elevated viscous resistance and abnormal flow behavior, even outside crisis states which leads to unstable interface and lower collection efficiency.
Performing RBC exchange immediately before collection may transiently reduce cellular activation.
Adjusting machine configuration by:
Increasing packing factor (centrifugal force) to compensate for increased viscosity
Collecting deeper within the buffy coat (accepting higher product Hct) improves CD34 and CE.”
Title: Challenges and limitations of mobilization and stem cell collection for gene therapy of sickle cell disease
Authors: Yvette C Tanhehco , Suzanne Thibodeaux , Patricia A Shi , Stella T Chou , Shannon A Kelly , Grace Fortes Monis , Carly Newton , Kamille West-Mitchell , Yan Zheng , Christine Fernandez , Christina Anderson , Kimberly Ching , Victoria Coleman-Cowger , Adrienne Shapiro , John P Manis

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 21, 2026, 15:02Sham Zamil: The Role of ABO Compatibility in Platelet Pooling
-
Jul 21, 2026, 13:43Dima Shulkin: Assessing AI-Driven Blood Test Screening for Colorectal Cancer
-
Jul 21, 2026, 13:24Benoit Mores: National Initiative Targets Better Cardiovascular Outcomes
-
Jul 21, 2026, 13:10Paolo Zamboni: Chronic Cerebrospinal Venous Insufficiency Hypothesis in Multiple Sclerosis
-
Jul 21, 2026, 13:05Danai Poutakidou։ The Diagnostic Pitfalls of Unexpected PT/INR Prolongation
-
Jul 21, 2026, 13:00Kefah Mokbel: Beyond Thromboprophylaxis – Enoxaparin’s Emerging Anticancer Signal
-
Jul 21, 2026, 12:56Emmanuel Velazquez-Alvarez: Bridging Innovation and Clinical Practice
-
Jul 21, 2026, 12:53Sandrine Bouteille: A Milestone Presentation at ISTH 2026
-
Jul 21, 2026, 12:40Kalled Musallam: A Comprehensive Review of Thalassemia